Back to Top Skip to main content

Medical research and development take center stage at symposium

The theme of this year’s meeting is “Medical Innovation for Warfighter Readiness.” The theme of this year’s meeting is “Medical Innovation for Warfighter Readiness.”

Recommended Content:

MHSRS 2019 | Research and Innovation

FALLS CHURCH, Va. — Sharing scientific knowledge gained from military-unique medical research and development is the focus of the annual Military Health System Research Symposium, Aug. 20-23 at the Gaylord Palms Resort and Convention Center in Kissimmee, Florida. The theme of this year’s meeting is “Medical Innovation for Warfighter Readiness: The Future Starts Now.”

 “MHSRS is the premier showcase for our research community,” said Dr. Terry Rauch, acting deputy assistant secretary of Defense for Health Readiness Policy and Oversight at the Defense Health Agency. 

“Attendees will be able to meet with colleagues from around the world in industry, academia, and across governments while learning about all of the new and exciting advancements in military medical research," said Rauch. 

Navy Vice Adm. Raquel Bono, DHA director, is attending the symposium. She will be among approximately 3,000 others including military providers with deployment experience, research and academic scientists, and industry and international partners.

Biomedical research and development is a vital part of national security strategy, said Navy Rear Adm. Mary Riggs, DHA’s director of research and development. She said R&D leads to advances that ensure service members are better protected, better prepared, and better cared for as they execute their mission.

Topics covered during the symposium include combat casualty care, military operational medicine including psychological health and resilience, clinical and rehabilitative medicine, medical simulation and health information sciences, military infectious diseases, and radiation health. The Aug. 20 session includes the presentation of the 2018 MHSRS awards for Distinguished Service, individual research accomplishment, and outstanding research team.

Sean Biggerstaff, deputy director of DHA’s Research and Development directorate, said innovative breakthroughs are needed for maximum readiness in the future.

 “With appropriate processes in place, our organization can achieve these goals and provide interoperable products to the future force,” Biggerstaff said.

“Today’s development of efficient and effective military biomedical R&D processes will help speed the delivery of products and solutions in the future,” he said.

MHSRS is the premier military or civilian meeting that focuses specifically on the unique medical needs of warfighters, providing a collaborative setting for the exchange of information. Additional information about MHSRS is available here.

You also may be interested in...

DHA-PI 3200.01: Research and Development (R&D) Enterprise Activity (EA)

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (p): a. Establishes the Defense Health Agency’s (DHA) procedures for the Deputy Assistant Director (DAD), R&D to manage and execute, on behalf of the Assistant Secretary of Defense for Health Affairs (ASD(HA)), the portion of the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation assigned to it (referred to as the “DHP Science and Technology (S&T) Program)”. The DHP S&T Program includes Budget Activities (BAs) 6.1-6.3 and 6.6. The ASD(HA) provides policy, direction, and guidance to inform planning, programming, budgeting, and execution of the DHP RDT&E appropriation in accordance with statute, regulation, and policy in Reference (a). The DAD-R&D, and Component Acquisition Executive (CAE) manage and execute DHP RDT&E Program funds aligned to them on behalf of the ASD(HA). The CAE is responsible for managing BAs 6.4, 6.5, and 6.7 funding, as well as Procurement and Operations and Maintenance funding required to support DHP-funded Acquisition Programs, regardless of acquisition activity. b. Supports the Director, DHA, in developing appropriate DHA management models to maximize efficiencies in the management and execution of DHP RDT&E-funded activities carried out by the Combatant Commands (CCMDs), Services, Uniformed Services University of the Health Sciences (USU), Defense Agencies, and other DoD Components, as applicable. c. Codifies processes to confirm DHP RDT&E funds are applied towards medical priorities and aligned to ASD(HA) policy, direction, and guidance to develop and deliver innovative medical products and solutions that increase the readiness of the DoD medical mission in accordance with Reference (a). d. Supports the following objectives of the R&D EA: (1) Increasing the quantity, quality, and pace of medical research through improved programmatic organization, processes, and oversight. (2) Ensuring DHP RDT&E funded efforts align to ASD(HA) published program guidance that provides resourcing guidance and translates national, departmental, and Service priorities into specific program objectives. (3) Verifying alignment of DHP RDT&E funds to medical priorities and to ASD(HA) policy, direction, and guidance to ensure the development and delivery of medical materiel and knowledge solutions. (4) Facilitating coordination with the CCMDs, Services, USU, Defense Agencies, and other DoD Components, as applicable, to ensure DHP RDT&E funded activities address joint medical capability gaps, and avoid unnecessary duplication.

Guidance on the Establishment of a Human Cell, Tissue, and Cellular and Tissue Based Products Program

Policy

This memorandum requests the Services resource a Human Cell, Tissue, and Cellular and Tissue Based Products (HCT/Ps) Program that complies with regulatory standards for management and oversight of HCT/Ps, according to the best fit for their Service.

<< < 1 > >> 
Showing results 1 - 2 Page 1 of 1

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing; Download a PDF Reader or learn more about PDFs.